Skip to content
10-K

Annual Report

UPSTREAM BIO, INC. UPB

0000950170-25-037621

← back to feed
Filed
Mar 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 5, 2025 53.64M sh
Shares Diluted FY 2024 · Dec 31, 2023 2.95M sh
Capex FY 2024 · Dec 31, 2023 $144K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$37.93M
Short Term Investments FY 2024 · Dec 31, 2023 $83.98M
Cash And Equivalents FY 2024 · Dec 31, 2023 $25.83M
Current Liabilities FY 2024 · Dec 31, 2023 $6.52M
Total Liabilities FY 2024 · Dec 31, 2023 $9.39M
Current Assets FY 2024 · Dec 31, 2023 $117M
Total Assets FY 2024 · Dec 31, 2023 $117.2M
Eps Diluted FY 2024 · Dec 31, 2023 −$12.95
Eps Basic FY 2024 · Dec 31, 2023 −$12.95
Sga Expense FY 2024 · Dec 31, 2023 $10.7M
Rd Expense FY 2024 · Dec 31, 2023 $31.8M
Net Income FY 2024 · Dec 31, 2023 −$20.54M
Operating Income FY 2024 · Dec 31, 2023 −$40.11M
Revenue FY 2024 · Dec 31, 2023 $2.38M
Stockholders Equity FY 2024 · Dec 31, 2022 −$106.16M